These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1878535)

  • 1. Bioavailability of diltiazem as a function of the administered dose.
    Bianchetti G; Regazzi M; Rondanelli R; Ascalone V; Morselli PL
    Biopharm Drug Dispos; 1991 Jul; 12(5):391-401. PubMed ID: 1878535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration.
    Yeung PK; Mosher SJ; Pollak PT
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):69-74. PubMed ID: 1936064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between diltiazem and nortriptyline.
    Krähenbühl S; Smith-Gamble V; Hoppel CL
    Eur J Clin Pharmacol; 1996; 49(5):417-9. PubMed ID: 8866640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules.
    Du Souich P; Lery N; Lery L; Varin F; Boucher S; Vezina M; Pilon D; Spenard J; Caillé G
    Biopharm Drug Dispos; 1990 Mar; 11(2):137-47. PubMed ID: 2328299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of diltiazem and its metabolites after repeated single dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):551-7. PubMed ID: 2815230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA; Choi DH; Choi JS
    J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pharmacokinetics, bioavailability and dose linearity of diltiazem in healthy volunteers.
    Hutt V; Janik F; Kappler J; Pabst G; Ravelli V; Maccari M; Jaeger H
    Arzneimittelforschung; 1993 Jul; 43(7):737-43. PubMed ID: 8369005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1989 Sep; 11(5):558-66. PubMed ID: 2815231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of two tablet preparations of diltiazem in healthy volunteers.
    De Bernardis E; Candido P; Lorefice R; Picari M; Rizza V
    Arzneimittelforschung; 1992 Jan; 42(1):25-7. PubMed ID: 1586376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of a sustained-release diltiazem formulation (Mono-Tildiem LP 300 MG) after repeated administration in healthy volunteers.
    Bianchetti G; Dubruc C; Sultana V; Houin G; Rosenzweig P
    Eur J Clin Pharmacol; 1995; 48(3-4):259-64. PubMed ID: 7589051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and absolute bioavailability of diltiazem in humans.
    Ochs HR; Knüchel M
    Klin Wochenschr; 1984 Apr; 62(7):303-6. PubMed ID: 6727272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and pharmacokinetics of a new sustained-release formulation of diltiazem.
    Thiercelin JF; Necciari J; Caplain H; Cournot A; Combes M; Desmolin H; Flouvat B
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S31-7. PubMed ID: 1706011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatment.
    Bialer M; Hadad S; Golomb G; Barel S; Samara E; Abu Salach O; Berkman N; Danenberg HD; Ben David J; Caron D
    Biopharm Drug Dispos; 1994 Jan; 15(1):45-52. PubMed ID: 8161715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bioavailability and pharmacodynamics of diltiazem from two pharmaceutical preparations.
    Dange SV; Nandal DH; Gokhale VS; Shah KU; Kadam DB
    Indian J Physiol Pharmacol; 1992 Jul; 36(3):205-8. PubMed ID: 1473854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P-gp Inhibition.
    Athukuri BL; Neerati P
    Phytother Res; 2017 Sep; 31(9):1441-1448. PubMed ID: 28766866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose.
    Boyd RA; Chin SK; Don-Pedro O; Verotta D; Sheiner LB; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Oct; 46(4):408-19. PubMed ID: 2791444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of diltiazem after intravenous and oral administration.
    Hermann P; Rodger SD; Remones G; Thenot JP; London DR; Morselli PL
    Eur J Clin Pharmacol; 1983; 24(3):349-52. PubMed ID: 6861848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single and multiple oral dose pharmacokinetics of clentiazem in normal volunteers.
    Bhargava VO; Shah AK; Weir SJ; Nordbrock EE; Giesing DH
    J Clin Pharmacol; 1993 May; 33(5):439-43. PubMed ID: 8331200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.